Musa Tariq - 15 Sep 2026 Form 4 Insider Report for Guardant Health, Inc. (GH)

Reporting relationship: Director
Issuer ticker: GH
Reported as of: 15 Sep 2026
Net transaction value: -$20,300
SEC form: 4
Accepted by SEC: 17 Sep 2026, 17:09:28 UTC
Prior SEC filing: 18 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/ John G. Saia, as attorney-in-fact for Musa Tariq

Key filing fact

Musa Tariq filed Form 4 for Guardant Health, Inc. (GH) on 17 Sep 2026.

Key facts

This page summarizes Musa Tariq's Form 4 filing for Guardant Health, Inc. (GH).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 17 Sep 2026, 17:09.

Change

Previous filing in this sequence was filed on 18 Aug 2026.
Current net transaction value: -$20,300.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001968281 Primary reporting owner

Tariq Musa

Relationship: Director
Address: 3100 HANOVER STREET, PALO ALTO
Signature: /s/ John G. Saia, as attorney-in-fact for Musa Tariq
Signature date: 17 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GH transaction

Common Stock

Options Exercise

Transaction value
Shares: +249
Change %: +2.2%
Price: $0.000000^*
Shares after: 11,565
Date: 15 Sep 2026
Ownership: Direct

GH transaction

Common Stock

Sale

Transaction value: $20,300
Shares: -116
Change %: -1%
Price: $175.00
Shares after: 11,449
Date: 16 Sep 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GH transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -249
Change %: -14%
Price: $0.000000^*
Shares after: 1,500
Date: 15 Sep 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 249
Exercise price: $0.000000
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

The restricted stock unit award granted on March 6, 2023 vests over a four-year period. 25% of the shares subject to such award vested on March 15, 2024 and the remaining 75% vests monthly for the three-year period thereafter.

Footnote F2

Not applicable for Restricted Stock Units.